S
Sanjay Kaul
Researcher at Cedars-Sinai Medical Center
Publications - 222
Citations - 25862
Sanjay Kaul is an academic researcher from Cedars-Sinai Medical Center. The author has contributed to research in topics: Randomized controlled trial & Myocardial infarction. The author has an hindex of 67, co-authored 215 publications receiving 22556 citations. Previous affiliations of Sanjay Kaul include University of California, Los Angeles & Baylor University Medical Center.
Papers
More filters
Journal ArticleDOI
Is homocysteine a relevant cardiovascular risk factor
Jayanta R. Das,Sanjay Kaul +1 more
TL;DR: The overall evidence suggests a null effect, thereby failing to validate the hypothesis that a reduction in homocysteine levels would result in clinical benefit, and illustrates why the use of homocy steine as a screening tool or a target of cardiovascular treatment cannot be recommended.
Journal ArticleDOI
Aspirin therapy for primary versus secondary prevention of cardiovascular disease: an updated meta-analysis.
Journal ArticleDOI
Harold James Charles ("Jeremy") Swan, MD, PhD
Journal ArticleDOI
Safety and Efficacy of Empagliflozin and Diuretic Use in Patients with Heart Failure and Preserved Ejection Fraction
Javed Butler,Muhammad Usman,Gerasimos Filippatos,João Pereira,Michael Böhm,Martina Brueckmann,James L. Januzzi,Sanjay Kaul,Ileana L. Piña,Piotr Ponikowski,Michele Senni,Mikhail Sumin,Subodh Verma,Liliana Zaremba-Pechmann,Stuart J. Pocock,Milton Packer,Stefan D. Anker +16 more
TL;DR: In this article , the safety and efficacy of empagliflozin in patients with heart failure and preserved ejection fraction (HFpEF) with background diuretic use was investigated.